Bacterial and mycobacterial meningitis in HIV-positive compared with HIV-negative patients in an internal medicine ward in Libreville, Gabon [1]

Journal of Acquired Immune Deficiency Syndromes

Volumn 32, Issue 3, 2003, Pages 345-346

  Nkoumou, Madeleine Okome ^a   Betha, Gervais ^a   Kombila, Maryvone ^b   Clevenbergh, Philippe ^c  

^a Fondation Jeanne Ebori ^*  (Gabon)

^b UNIVERSITÉ DES SCIENCES DE LA SANTÉ   (Gabon)

^c HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; ETHAMBUTOL; ISONIAZID; PNEUMOCOCCUS VACCINE; PYRAZINAMIDE; RIFAMPICIN;

BACTERIAL MENINGITIS; CELLULAR IMMUNITY; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; GABON; HELPER CELL; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; LETTER; MAJOR CLINICAL STUDY; MEDICAL RECORD; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SEX RATIO; SIDE EFFECT; TUBERCULOUS MENINGITIS; WARD;

ADULT; FEMALE; GABON; HIV SEROPOSITIVITY; HOSPITAL UNITS; HUMANS; INTERNAL MEDICINE; MALE; MENINGITIS, BACTERIAL; TUBERCULOSIS, MENINGEAL;

EID: 0037340712     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200303010-00016     Document Type: Letter

References (12)

1. Caracelain G, Autran B. Mécanismes immuno-pathologiques de l'infection VIH. In: Girard PM, Katlama C, Pialcux G, eds. VIH 2001, eds. Doin.
2. Nuorti JP, Butler JC, Gelling L, et al. Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California. Ann Intern Med 20001;32:182-90.
3. Programme National de Lutte contre le SIDA, Gabon. Rapport d'activité du Département d'Epidémiologie 2000.
4. Almirante B, Saballs M, Ribera E, et al. Favorable prognosis of purulent meningitis in patients infected with human immunodeficiency virus. Clin Infect Dis 1998;27:176-80.
5. Gordon SB, Walsh AL, Chaponda M, et al. Bacterial meningitis in Malawian adults: pneumococcal disease is common, severe, and seasonal. Clin Infect Dis 2000;31:53-7.
6. Dworkin MS, Ward JW, Hanson DL, et al. Adult and Adolescent Spectrum of HIV Disease Project. Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination. Clin Infect Dis 2001;32:794-800.
7. DiRienzo AG, van Der Horst C, Finkelstein DM, et al. Efficacy of trimethoprim-sulfamethoxazole for the prevention of bacterial infections in a randomized prophylaxis trial of patients with advanced HIV infection. AIDS Res Hum Retroviruses 2002;18: 89-94.
8. Pearson IC, Baker R, Sullivan AK, et al. Meningococcal infection in patients with the human immunodeficiency virus and acquired immunodeficiency syndrome. Int J STD AIDS 2001;12:410-11.
9. Yechoor VK, Shandera WX, Rodriguez P, et al. Tuberculous meningitis among adults with and without HIV infection: experience in an urban public hospital. Arch Intern Med 1996;156:1710-16.
10. de Pinho AM, Santoro-Lopes G, Harrison LH, et al. Chemoprophylaxis for tuberculosis and survival of HIV-infected patients in Brazil. AIDS 2001;15:2129-35.
11. Wilkinson D. Drugs for preventing tuberculosis in HIV infected persons. Cochrane Database Syst Rev 2000;(4):CD000171.
12. Santoro-Lopes G, de Pinho AM, Harrison LH, et al. Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy. Clin Infect Dis 2002;34:543-6.